| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.3 |